• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Danaher

Danaher

BlackRock LifePath® Active 2050 R BRPKX 2 Star

Last Price$10.18Day Change (%)0.10%
Open Price$10.18Day Change ($)0.01
Day Range10.18–10.1852-Week Range8.23–10.28

As of Fri 12/08/2016 | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Dental Implants and Prosthetics Market Analysis & Trends - Expected to Reach $17 Billion by 2025 - Research and Markets

    Global Dental Implants and Prosthetics Market Analysis & Trends - Expected to Reach $17 Billion by 2025 - Research and Markets

  2. Global Point of care Molecular Diagnostics Market Analysis & Trends - Technology, Test Location & Application - Forecast to 2025 - Research and Markets

    Global Point of care Molecular Diagnostics Market Analysis & Trends - Technology, Test Location & Application - Forecast to 2025 - Research and Markets

  3. Test and Measurement Market - Analysis, Technologies & Forecasts to 2021 - Expansion of 4G Network in APAC Driving Growth - Research and Markets

    Test and Measurement Market - Analysis, Technologies & Forecasts to 2021 - Expansion of 4G Network in APAC Driving Growth - Research and Markets

  4. Gap Names Former Kraft Finance Chief as Next CFO -- Update

    Gap Names Former Kraft Finance Chief as Next CFO -- Update

  5. Ultimate Stock-Pickers’ Top 10 High-Conviction and New-Money Purchases

    Top managers were finding new places to put money to work and adding to existing high-conviction ideas in the first quarter.

  6. Ultimate Stock-Pickers: Top 10 Buys and Sells

    Top managers continue to find opportunities for some new-money purchases, while taking full advantage of a rising stock market to book gains in shares trading above their fair value estimates.

  7. Buy the Unloved 2015

    Going against the grain of flows can be a profitable strategy.

  8. Buy the Unloved 2015

    Going against the grain of flows can be a profitable strategy.

  9. Fed Taper Not Likely in the Cards for 2013

    As the economy remains soft and uncertain, Fed tapering is now more likely a 2014 event, writes Morningstar's Bob Johnson.

  10. Behind T. Rowe Price Capital Appreciation's Gold Rating

    The following is an excerpt from Morningstar's Premium Analyst Report for T. Rowe Price Capital Appreciation PRWCX, a moderate allocation fund that receives a Gold Fund Analyst Rating from Morningstar analysts. Morningstar.com Premium Members can  click here to see the full Analyst Report. Not a ...

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.